New Market Report: CytoCore, Inc. (CYOE) - Product Pipeline Analysis, 2014 Update
CytoCore, Inc. (CCI), formerly Molecular Diagnostics, Inc., is a biotechnology company. It undertakes the design, development and commercialization of cost-effective screening systems for the early detection of cancer. The major product developed by the company is CytoCore Solutions System, a simple and cost-effective method to screen women for endometrial cancer. It consists of four distinct components, namely, the SoftPAP cervical cell collector, the AIPS microscope platform, drug delivery system for treating cervical lesions, and a protein-based biochemical cocktails and slide-based...
View full press release